Literature DB >> 22289868

Increased numbers of eosinophils, rather than only etiology, predict histologic changes in patients with esophageal eosinophilia.

Srividya Sridhara1, Karthik Ravi, Thomas C Smyrk, Hirohito Kita, Gail M Kephart, Catherine R Weiler, David A Katzka.   

Abstract

BACKGROUND & AIMS: It can be a challenge to differentiate individuals with eosinophilic esophagitis (EoE) from those with gastroesophageal reflux disease (GERD). We investigated differences in histologic and eosinophil patterns and numbers of mast cells between patients with these disorders.
METHODS: We performed histologic analyses and immunohistochemical assays for eosinophil-derived neurotoxin (EDN), major basic protein (MBP), and tryptase, using biopsy samples from 10 patients with GERD (positive results from a pH study and response to proton pump inhibitors), Barrett's esophagus, or EoE (negative results from a pH study and positive response to budesonide). Patients were matched for degree of eosinophilia.
RESULTS: Samples from patients with EoE, GERD, or Barrett's esophagus had similar increases in concentrations of eosinophils. Patients with GERD or EoE did not differ in amount of basal zone hyperplasia, microabscesses, spongiosis, eosinophil distribution, maximum eosinophils/high-power field (HPF), or composite histologic scores. Samples from all 3 groups had high levels of EDN and MBP; the levels of eosinophil products were correlated (ρ = 0.93). Extracellular staining for EDN was greater than intracellular staining (2.67 of 3 vs 1.86 of 3); levels tended to be greater in samples from patients with EoE than GERD (P = .05) or Barrett's esophagus (P = .06). Detection of EDN correlated with peak numbers of eosinophils/HPF (ρ = 0.6 for intracellular and extracellular staining). Peak numbers of tryptase-positive mast cells/HPF were significantly greater in samples from patients with EoE than GERD or Barrett's esophagus (P = .01 and .005, respectively). The Spearman correlation between eosinophil and mast cell density was a ρ value of 0.2.
CONCLUSIONS: Biopsy samples from patients with GERD and EoE, matched for esophageal eosinophilia, have similar changes in histology and levels of EDN and MBP, whereas mast cells from patients with EoE have higher levels of these products. The presence of esophageal eosinophils, rather than etiology, could be the most important determinant of epithelial response.
Copyright © 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22289868     DOI: 10.1016/j.cgh.2012.01.008

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  11 in total

1.  Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis.

Authors:  Evan S Dellon; Xiaoxin Chen; C Ryan Miller; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2012-07-10       Impact factor: 10.864

Review 2.  Eosinophilic Esophagitis.

Authors:  Glenn T Furuta; David A Katzka
Journal:  N Engl J Med       Date:  2015-10-22       Impact factor: 91.245

Review 3.  The Immunologic Mechanisms of Eosinophilic Esophagitis.

Authors:  David A Hill; Jonathan M Spergel
Journal:  Curr Allergy Asthma Rep       Date:  2016-02       Impact factor: 4.806

4.  Extracellular Eosinophil Granule Protein Deposition in Ringed Esophagus with Sparse Eosinophils.

Authors:  Kathryn A Peterson; William J Cobell; Frederic C Clayton; Chaya Krishnamurthy; Jian Ying; Leonard F Pease; Hedieh Saffari; Ann Georgelas; John Fang; Gerald J Gleich; Kristin M Leiferman
Journal:  Dig Dis Sci       Date:  2015-04-23       Impact factor: 3.199

5.  Effect of proton pump inhibitor on esophageal eosinophilia.

Authors:  Shauna Schroeder; Kelley E Capocelli; Joanne C Masterson; Rachel Harris; Cheryl Protheroe; James J Lee; Glenn T Furuta
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-02       Impact factor: 2.839

6.  Eosinophilic esophagitis: interactions with gastroesophageal reflux disease.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart Jon Spechler
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

7.  Emerging therapeutic options for eosinophilic esophagitis.

Authors:  Timothy Dougherty; Sindu Stephen; Marie L Borum; David B Doman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-02

8.  Pathogenic role of mast cells in experimental eosinophilic esophagitis.

Authors:  Rituraj Niranjan; Parm Mavi; Madhavi Rayapudi; Scott Dynda; Anil Mishra
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-04-18       Impact factor: 4.052

Review 9.  Recent advances in understanding/managing eosinophilic esophagitis in adults.

Authors:  David A Katzka
Journal:  F1000Res       Date:  2015-08-20

10.  Diagnosis of Pediatric Non-Esophageal Eosinophilic Gastrointestinal Disorders by Eosinophil Peroxidase Immunohistochemistry.

Authors:  Shaina H Hasan; Steve Taylor; Shipra Garg; Matthew R Buras; Alfred D Doyle; Cindy S Bauer; Benjamin L Wright; Shauna Schroeder
Journal:  Pediatr Dev Pathol       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.